Cardiol Therapeutics Ownership 2024 | Who Owns Cardiol Therapeutics Now?
Institutional Ownership
3.24%
Insider Ownership
4.57%
Retail Ownership
92.19%
Institutional Holders
19.00
Cardiol Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEJARA CAPITAL LTD | 2.56% | 1.26% | 1,722,243 | 77,833 | 4.73% | 3,478,931 | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | 2.18% | 0.51% | 1,466,972 | 164,994 | 12.67% | 2,933,944 | Jun 30, 2024 |
| MMCAP INTERNATIONAL INC. SPC | 1.37% | 0.26% | 924,125 | -1,642,000 | -63.99% | 1,866,732 | Jun 30, 2024 |
| LION STREET ADVISORS, LLC | 0.38% | 0.19% | 253,281 | 60,581 | 31.44% | 505,377 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.17% | 0.00% | 116,131 | -12,612 | -9.80% | 235,000 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.15% | 0.03% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.15% | 0.14% | 100,000 | 100,000 | 100.00% | 202,000 | Jun 30, 2024 |
| MGO ONE SEVEN LLC | 0.15% | 0.01% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.08% | - | 55,000 | 55,000 | 100.00% | 111,100 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.08% | - | 52,435 | - | - | 105,918 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.07% | - | 50,112 | 112 | 0.22% | 106,241 | Jun 30, 2024 |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 0.07% | 0.00% | 48,000 | 48,000 | 100.00% | 96,960 | Jun 30, 2024 |
| MARBLE HARBOR INVESTMENT COUNSEL, LLC | 0.05% | 0.01% | 36,900 | - | - | 74,538 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.04% | 0.00% | 29,294 | 29,294 | 100.00% | 58,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.04% | 0.00% | 29,028 | 29,028 | 100.00% | 34,430 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.00% | 28,292 | 24,625 | 671.53% | 57,150,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.04% | - | 27,300 | 27,300 | 100.00% | 55,146 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.04% | - | 27,105 | 10,676 | 64.98% | 55,000 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.04% | - | 26,167 | 787 | 3.10% | 52,460 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.03% | - | 23,500 | - | - | 47,470 | Jun 30, 2024 |
Cardiol Therapeutics's largest institutional shareholder is TEJARA CAPITAL LTD, holding 2.56% of the company's total share outstanding, currently valued at $3.48M. The top 10 institutional shareholders own together 7.27% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEJARA CAPITAL LTD | 2.56% | 1.26% | 1,722,243 | 77,833 | 4.73% | 3,478,931 | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | 2.18% | 0.51% | 1,466,972 | 164,994 | 12.67% | 2,933,944 | Jun 30, 2024 |
| MMCAP INTERNATIONAL INC. SPC | 1.37% | 0.26% | 924,125 | -1,642,000 | -63.99% | 1,866,732 | Jun 30, 2024 |
| LION STREET ADVISORS, LLC | 0.38% | 0.19% | 253,281 | 60,581 | 31.44% | 505,377 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.15% | 0.14% | 100,000 | 100,000 | 100.00% | 202,000 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.15% | 0.03% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| MGO ONE SEVEN LLC | 0.15% | 0.01% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| PISCATAQUA SAVINGS BANK | 0.01% | 0.01% | 5,000 | 2,000 | 66.67% | 10,250 | Jun 30, 2024 |
| MARBLE HARBOR INVESTMENT COUNSEL, LLC | 0.05% | 0.01% | 36,900 | - | - | 74,538 | Jun 30, 2024 |
| PRIVATE OCEAN, LLC | 0.02% | 0.00% | 15,151 | - | - | 30,605 | Jun 30, 2024 |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 0.07% | 0.00% | 48,000 | 48,000 | 100.00% | 96,960 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.04% | 0.00% | 29,028 | 29,028 | 100.00% | 34,430 | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.01% | 0.00% | 4,000 | 4,000 | 100.00% | 8,080 | Jun 30, 2024 |
| VALLEY NATIONAL ADVISERS INC | 0.01% | 0.00% | 5,000 | - | - | 10,000 | Jun 30, 2024 |
| RISE ADVISORS, LLC | 0.00% | 0.00% | 1,000 | - | - | 2,020 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.17% | 0.00% | 116,131 | -12,612 | -9.80% | 235,000 | Jun 30, 2024 |
| BENJAMIN EDWARDS INC | 0.00% | 0.00% | 875 | - | - | 2,000 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.02% | 0.00% | 11,165 | 11,165 | 100.00% | 22,553 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.00% | 28,292 | 24,625 | 671.53% | 57,150,000 | Jun 30, 2024 |
| SOUTHSTATE CORP | 0.00% | 0.00% | 1,000 | - | - | 2,020 | Jun 30, 2024 |
The largest Cardiol Therapeutics shareholder by % of total assets is TEJARA CAPITAL LTD. The company owns 1.72M shares of Cardiol Therapeutics (CRDL), representing 1.26% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | 2.18% | 0.51% | 1,466,972 | 164,994 | 12.67% | 2,933,944 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.15% | 0.14% | 100,000 | 100,000 | 100.00% | 202,000 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 2.56% | 1.26% | 1,722,243 | 77,833 | 4.73% | 3,478,931 | Jun 30, 2024 |
| LION STREET ADVISORS, LLC | 0.38% | 0.19% | 253,281 | 60,581 | 31.44% | 505,377 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.08% | - | 55,000 | 55,000 | 100.00% | 111,100 | Jun 30, 2024 |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 0.07% | 0.00% | 48,000 | 48,000 | 100.00% | 96,960 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.04% | 0.00% | 29,294 | 29,294 | 100.00% | 58,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.04% | 0.00% | 29,028 | 29,028 | 100.00% | 34,430 | Jun 30, 2024 |
| MORGAN STANLEY | 0.04% | - | 27,300 | 27,300 | 100.00% | 55,146 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.04% | 0.00% | 28,292 | 24,625 | 671.53% | 57,150,000 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.02% | 0.00% | 11,165 | 11,165 | 100.00% | 22,553 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 11,109 | 11,109 | 100.00% | 22,440 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.04% | - | 27,105 | 10,676 | 64.98% | 55,000 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.01% | - | 8,000 | 8,000 | 100.00% | 14,960 | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.01% | 0.00% | 4,000 | 4,000 | 100.00% | 8,080 | Jun 30, 2024 |
| PISCATAQUA SAVINGS BANK | 0.01% | 0.01% | 5,000 | 2,000 | 66.67% | 10,250 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.04% | - | 26,167 | 787 | 3.10% | 52,460 | Jun 30, 2024 |
| TORONTO DOMINION BANK | 0.00% | - | 803 | 700 | 679.61% | 1,622 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.07% | - | 50,112 | 112 | 0.22% | 106,241 | Jun 30, 2024 |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 0.00% | - | 50 | 50 | 100.00% | 101 | Jun 30, 2024 |
As of Jun 30 2024, Cardiol Therapeutics's largest institutional buyer is ADVISORSHARES INVESTMENTS LLC. The company purchased 164.99K stocks of CRDL, valued at $2.93M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MMCAP INTERNATIONAL INC. SPC | 1.37% | 0.26% | 924,125 | -1,642,000 | -63.99% | 1,866,732 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,200 | -24,400 | -95.31% | 2,424 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -14,681 | -100.00% | - | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -12,661 | -100.00% | - | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.17% | 0.00% | 116,131 | -12,612 | -9.80% | 235,000 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -11,154 | -100.00% | - | Jun 30, 2024 |
| CITY STATE BANK | - | - | - | -825 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 2,500 | -281 | -10.10% | 5,050 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 2,000 | -120 | -5.66% | 3,944 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.15% | 0.03% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| MGO ONE SEVEN LLC | 0.15% | 0.01% | 100,000 | - | - | 202,000 | Jun 30, 2024 |
| MARBLE HARBOR INVESTMENT COUNSEL, LLC | 0.05% | 0.01% | 36,900 | - | - | 74,538 | Jun 30, 2024 |
| PRIVATE OCEAN, LLC | 0.02% | 0.00% | 15,151 | - | - | 30,605 | Jun 30, 2024 |
| VALLEY NATIONAL ADVISERS INC | 0.01% | 0.00% | 5,000 | - | - | 10,000 | Jun 30, 2024 |
| RISE ADVISORS, LLC | 0.00% | 0.00% | 1,000 | - | - | 2,020 | Jun 30, 2024 |
| BENJAMIN EDWARDS INC | 0.00% | 0.00% | 875 | - | - | 2,000 | Jun 30, 2024 |
| SOUTHSTATE CORP | 0.00% | 0.00% | 1,000 | - | - | 2,020 | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | 0.01% | 0.00% | 6,900 | - | - | 18,906 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.08% | - | 52,435 | - | - | 105,918 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.03% | - | 23,500 | - | - | 47,470 | Jun 30, 2024 |
As of Jun 30 2024, Cardiol Therapeutics's biggest institutional seller is MMCAP INTERNATIONAL INC. SPC. The company sold -1.64M shares of CRDL, valued at $1.87M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 0.15% | 0.14% | 100,000 | 100,000 | 100.00% | 202,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.08% | - | 55,000 | 55,000 | 100.00% | 111,100 | Jun 30, 2024 |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 0.07% | 0.00% | 48,000 | 48,000 | 100.00% | 96,960 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.04% | 0.00% | 29,294 | 29,294 | 100.00% | 58,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.04% | 0.00% | 29,028 | 29,028 | 100.00% | 34,430 | Jun 30, 2024 |
| MORGAN STANLEY | 0.04% | - | 27,300 | 27,300 | 100.00% | 55,146 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.02% | 0.00% | 11,165 | 11,165 | 100.00% | 22,553 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 11,109 | 11,109 | 100.00% | 22,440 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.01% | - | 8,000 | 8,000 | 100.00% | 14,960 | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.01% | 0.00% | 4,000 | 4,000 | 100.00% | 8,080 | Jun 30, 2024 |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 0.00% | - | 50 | 50 | 100.00% | 101 | Jun 30, 2024 |
Cardiol Therapeutics's largest new institutional shareholder by number of shares is KNOLL CAPITAL MANAGEMENT, LLC, purchased 100.00K shares, valued at $202.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | - | - | - | -14,681 | -100.00% | - | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -12,661 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -11,154 | -100.00% | - | Jun 30, 2024 |
| CITY STATE BANK | - | - | - | -825 | -100.00% | - | Jun 30, 2024 |
Cardiol Therapeutics's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -14.68K shares, valued at -, as of undefined.
Cardiol Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Spinnaker ETF Series | 1.56% | 600,756 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.32% | 1,301,978 | 112,000 | 9.41% | Mar 28, 2024 |
| Investment Managers Series Trust II | 0.06% | 753,931 | - | - | Jan 31, 2024 |
| Global X Funds | 0.02% | 1,118,353 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.01% | 141,000 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 52,435 | - | - | Feb 29, 2024 |
Cardiol Therapeutics's largest mutual fund holder by % of total assets is "Spinnaker ETF Series", owning 600.76K shares, compromising 1.56% of its total assets.
Cardiol Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -48.65% |
| 31 Mar, 24 | 37 | 8.82% |
| 31 Dec, 23 | 34 | 3.03% |
| 30 Sep, 23 | 33 | 6.45% |
| 30 Jun, 23 | 31 | -3.13% |
| 31 Mar, 23 | 32 | 3.23% |
| 31 Dec, 22 | 31 | 14.81% |
| 30 Sep, 22 | 27 | -3.57% |
| 30 Jun, 22 | 28 | -9.68% |
| 31 Mar, 22 | 31 | -6.06% |
| 31 Dec, 21 | 33 | 83.33% |
| 30 Sep, 21 | 18 | - |
| 31 Dec, 20 | 1 | - |
| 30 Sep, 20 | 1 | - |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
As of 30 Jun 24, 19 institutions are holding Cardiol Therapeutics's shares, representing a decrease of -48.65% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,177,840 | -66.77% |
| 31 Mar, 24 | 6,554,685 | -5.21% |
| 31 Dec, 23 | 6,914,601 | 8.53% |
| 30 Sep, 23 | 6,371,323 | -4.72% |
| 30 Jun, 23 | 6,686,715 | -7.76% |
| 31 Mar, 23 | 7,249,047 | 7.35% |
| 31 Dec, 22 | 6,752,910 | 41.86% |
| 30 Sep, 22 | 4,760,289 | -10.51% |
| 30 Jun, 22 | 5,319,219 | -1.13% |
| 31 Mar, 22 | 5,379,806 | -7.21% |
| 31 Dec, 21 | 5,797,805 | 262.36% |
| 30 Sep, 21 | 1,599,991 | - |
| 31 Dec, 20 | 348,769 | 21.48% |
| 30 Sep, 20 | 287,106 | 17.91% |
| 30 Jun, 20 | 243,504 | 15.70% |
| 31 Mar, 20 | 210,470 | 9.23% |
| 31 Dec, 19 | 192,680 | - |
Cardiol Therapeutics (CRDL) has 2.18M shares outstanding as of 30 Jun 24, down -66.77% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.24% | 3.41% |
| 31 Mar, 24 | 9.75% | 8.71% |
| 31 Dec, 23 | 10.58% | 10.84% |
| 30 Sep, 23 | 9.88% | 9.08% |
| 30 Jun, 23 | 10.43% | 8.15% |
| 31 Mar, 23 | 11.31% | 10.10% |
| 31 Dec, 22 | 10.58% | 18.14% |
| 30 Sep, 22 | 7.64% | 10.35% |
| 30 Jun, 22 | 8.59% | 11.38% |
| 31 Mar, 22 | 8.69% | 4.83% |
| 31 Dec, 21 | 13.41% | 97.65% |
| 30 Sep, 21 | 3.71% | - |
| 31 Dec, 20 | 1.17% | 152.35% |
| 30 Sep, 20 | 0.88% | 114.58% |
| 30 Jun, 20 | 0.87% | 132.15% |
| 31 Mar, 20 | 0.81% | 146.07% |
| 31 Dec, 19 | 0.75% | - |
As of 30 Jun 24, Cardiol Therapeutics is held by 3.24% institutional shareholders, representing a 3.41% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -20.00% |
| 31 Mar, 24 | 10 | - |
| 31 Dec, 23 | 10 | -33.33% |
| 30 Sep, 23 | 15 | 36.36% |
| 30 Jun, 23 | 11 | -15.38% |
| 31 Mar, 23 | 13 | -18.75% |
| 31 Dec, 22 | 16 | 77.78% |
| 30 Sep, 22 | 9 | -25.00% |
| 30 Jun, 22 | 12 | -14.29% |
| 31 Mar, 22 | 14 | -33.33% |
| 31 Dec, 21 | 21 | 16.67% |
| 30 Sep, 21 | 18 | - |
| 31 Dec, 20 | 1 | - |
| 30 Sep, 20 | 1 | - |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
8 institutional shareholders have increased their position in CRDL stock as of 30 Jun 24 compared to 10 in the previous quarter (a -20.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -71.43% |
| 31 Mar, 24 | 7 | 40.00% |
| 31 Dec, 23 | 5 | 66.67% |
| 30 Sep, 23 | 3 | -62.50% |
| 30 Jun, 23 | 8 | 60.00% |
| 31 Mar, 23 | 5 | 25.00% |
| 31 Dec, 22 | 4 | -42.86% |
| 30 Sep, 22 | 7 | -12.50% |
| 30 Jun, 22 | 8 | 33.33% |
| 31 Mar, 22 | 6 | - |
| 31 Dec, 21 | 6 | - |
| 30 Sep, 21 | - | - |
| 31 Dec, 20 | - | - |
| 30 Sep, 20 | - | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
2 institutional shareholders have reduced their position in CRDL stock as of 30 Jun 24 compared to 7 in the previous quarter (a -71.43% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 19 | -48.65% | 2,177,840 | -66.77% | 3.24% | 3.41% | 8 | -20.00% | 2 | -71.43% |
| 31 Mar, 24 | 37 | 8.82% | 6,554,685 | -5.21% | 9.75% | 8.71% | 10 | - | 7 | 40.00% |
| 31 Dec, 23 | 34 | 3.03% | 6,914,601 | 8.53% | 10.58% | 10.84% | 10 | -33.33% | 5 | 66.67% |
| 30 Sep, 23 | 33 | 6.45% | 6,371,323 | -4.72% | 9.88% | 9.08% | 15 | 36.36% | 3 | -62.50% |
| 30 Jun, 23 | 31 | -3.13% | 6,686,715 | -7.76% | 10.43% | 8.15% | 11 | -15.38% | 8 | 60.00% |
| 31 Mar, 23 | 32 | 3.23% | 7,249,047 | 7.35% | 11.31% | 10.10% | 13 | -18.75% | 5 | 25.00% |
| 31 Dec, 22 | 31 | 14.81% | 6,752,910 | 41.86% | 10.58% | 18.14% | 16 | 77.78% | 4 | -42.86% |
| 30 Sep, 22 | 27 | -3.57% | 4,760,289 | -10.51% | 7.64% | 10.35% | 9 | -25.00% | 7 | -12.50% |
| 30 Jun, 22 | 28 | -9.68% | 5,319,219 | -1.13% | 8.59% | 11.38% | 12 | -14.29% | 8 | 33.33% |
| 31 Mar, 22 | 31 | -6.06% | 5,379,806 | -7.21% | 8.69% | 4.83% | 14 | -33.33% | 6 | - |
| 31 Dec, 21 | 33 | 83.33% | 5,797,805 | 262.36% | 13.41% | 97.65% | 21 | 16.67% | 6 | - |
| 30 Sep, 21 | 18 | - | 1,599,991 | - | 3.71% | - | 18 | - | - | - |
| 31 Dec, 20 | 1 | - | 348,769 | 21.48% | 1.17% | 152.35% | 1 | - | - | - |
| 30 Sep, 20 | 1 | - | 287,106 | 17.91% | 0.88% | 114.58% | 1 | - | - | - |
| 30 Jun, 20 | 1 | - | 243,504 | 15.70% | 0.87% | 132.15% | 1 | - | - | - |
| 31 Mar, 20 | 1 | - | 210,470 | 9.23% | 0.81% | 146.07% | 1 | - | - | - |
| 31 Dec, 19 | 1 | - | 192,680 | - | 0.75% | - | 1 | - | - | - |
CRDL Ownership FAQ
Who Owns Cardiol Therapeutics?
Cardiol Therapeutics is owned by institutional shareholders (3.24%), insiders (4.57%), and public (92.19%). The largest institutional shareholder of Cardiol Therapeutics is TEJARA CAPITAL LTD (2.56% of total shares) and the top mutual fund owner is Spinnaker ETF Series (1.56% of total shares).
Who are the major institutional shareholders of Cardiol Therapeutics?
Cardiol Therapeutics's major institutional shareholders are TEJARA CAPITAL LTD, ADVISORSHARES INVESTMENTS LLC, MMCAP INTERNATIONAL INC. SPC, LION STREET ADVISORS, LLC, and CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.. The top five shareholders own together 6.67% of the company's share outstanding.
How many Cardiol Therapeutics shareholders are there?
As of Jun 2024, there are 19 institutional shareholders of Cardiol Therapeutics.
What percentage of Cardiol Therapeutics is owned by TEJARA CAPITAL LTD?
TEJARA CAPITAL LTD owns 1.72M shares of Cardiol Therapeutics, representing 2.56% of the company's total shares outstanding, valued at $3.48M (as of Jun 2024).
What percentage of Cardiol Therapeutics is owned by ADVISORSHARES INVESTMENTS LLC?
As of Jun 2024, ADVISORSHARES INVESTMENTS LLC holds 1.47M shares of Cardiol Therapeutics (CRDL), compromising 2.18% of the company, valued at $2.93M.
What percentage of Cardiol Therapeutics is owned by MMCAP INTERNATIONAL INC. SPC?
MMCAP INTERNATIONAL INC. SPC is the third largest holder of Cardiol Therapeutics. The company owns 924.12K of the company's shares outstanding (worth $1.87M).